Abstract
This study was performed to determine whether minoxidil sulfate (MS), a selective Adenosine 5′-triphosphate-sensitive potassium channel (K ATP channel) activator, has an effect on the expression of caveolin-1 in the rat’s brain tumor tissue. Using a rat brain glioma (C6) model, we found that the expression of caveolin-1 protein at tumor sites was greatly increased after intracarotid infusion of MS at a dose of 30 μg/kg/min for 15, 30, and 60 min via Western blot analysis. And the peak value of the caveolin-1 expression was observed in rats with glioma after 15 min of MS perfusion, which was significantly attenuated by reactive oxygen species (ROS) scavenger (N-2-mercaptopropionyl glycine, MPG). In addition, MPG also significantly inhibited the increase of blood–brain tumor barrier (BTB) permeability which was induced by MS. This led to the conclusion that the MS-induced BTB permeability increase may be related to the accelerated formation of caveolin-1 protein, and could be mediated by ROS.
Similar content being viewed by others
References
Bartholomew JN, Galbiati F (2010) Mapping of oxidative stress response elements of the caveolin-1 promoter. Methods Mol Biol 594:409–423
Beauchesne E, Desjardins P, Butterworth RF, Hazell AS (2010) Up-regulation of caveolin-1 and blood-brain barrier breakdown are attenuated by N-acetylcysteine in thiamine deficiency. Neurochem Int 57:830–837
Cao C, Healey S, Amaral A, Lee-Couture A, Wan S, Kouttab N, Chu W, Wan Y (2007) ATP-sensitive potassium channel: a novel target for protection against UV-induced human skin cell damage. J Cell Physiol 212(1):252–263
Drab M, Verkade P, Elger M, Kasper M, Lohn M, Lauterbach B, Menne J, Lindschau C, Mende F, Luft FC, Schedl A, Haller H, Kurzchalia TV (2001) Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 293:2449–2452
Drappatz J, Schiff D, Kesari S, Norden AD, Wen PY (2007) Medical management of brain tumor patients. Neurol Clin 25:1035–1071
Goñi-Allo B, Puerta E, Ramos M, Lasheras B, Jordán J, Aguirre N (2008) Minoxidil prevents 3,4-methylenedioxymethamphetamine-induced serotonin depletions: role of mitochondrial ATP-sensitive potassium channels, Akt and ERK. J Neurochem 104:914–925
Hayashi Y, Yoshida Y, Hamada J (2006) Blood-tumor barrier in malignant brain tumor. No Shinkei Geka 34:983–999
Heinen A, Camara AK, Aldakkak M, Rhodes SS, Riess ML, Stowe DF (2007) Mitochondrial Ca2+-induced K+ influx increases respiration and enhances ROS production while maintaining membrane potential. Am J Physiol Cell Physiol 292:C148–C156
Komarova Y, Malik AB (2010) Regulation of endothelial permeability via paracellular and transcellular transport pathways. Annu Rev Physiol 72:463–493
Lajoie P, Nabi IR (2007) Regulation of raft-dependent endocytosis. J Cell Mol Med 11:644–653
Laquintana V, Trapani A, Denora N, Wang F, Gallo JM, Trapani G (2009) New strategies to deliver anticancer drugs to brain tumors. Expert Opin Drug Deliv 6:1017–1032
Lee SW, Kim WJ, Park JA, Choi YK (2006) Blood–brain barrier interfaces and brain tumors. Arch Pharm Res 29:265–275
Liang Hua-wei, Xia Qiang (2005) Reactive oxygen species mediate neuroprotection induced by mitochondrial ATP-sensitive potassium channel opener in rat hippocampal slices during hypoxia. Chin J Pathophysiol 21:2018–2021
Nag S, Venugopalan R, Stewart DJ (2007) Increased caveolin-1 expression precedes decreased expression of occludin and claudin-5 during blood-brain barrier breakdown. Acta Neuropathol l114:459–469
Ningaraj NS, Rao MK, Black KL (2003) Adenosine 5′-triphosphate-sensitive potassium channel-mediated blood–brain tumor barrier permeability increase in a rat brain tumor model. Cancer Res 63:8899–8911
Ningaraj NS, Sankpal UT, Khaitan D, Meister EA, Vats T (2009) Activation of KATP channels increases anticancer drug delivery to brain tumors and survival. Eur J Pharmacol 602:188–193
Quest AF, Gutierrez-Pajares JL, Torres VA (2008) Caveolin-1: an ambiguous partner in cell signalling and cancer. J Cell Mol Med 12:1130–1150
Salama NN, Eddington ND, Fasano A (2006) Tight junction modulation and its relationship to drug delivery. Adv Drug Deliv Rev 58:15–28
Sun SW, Zu XY, Tuo QH, Chen LX, Lei XY, Li K, Tang CK, Liao DF (2010) Caveolae and caveolin-1 mediate endocytosis and transcytosis of oxidized low density lipoprotein in endothelial cells. Acta Pharmacol Sin 31:1336–1342
Zhong Y, Smart EJ, Weksler B, Couraud PO, Hennig B, Toborek M (2008) Caveolin-1 regulates human immunodeficiency virus-1 Tat-induced alterations of tight junction protein expression via modulation of the Ras signaling. J Neurosci 28:7788–7796
Acknowledgments
This study was supported by doctor-beginning science foundation of Liaoning Province in China, No. 20101109, and special fund for scientific research of doctor-degree subject for the new teacher in colleges and universities in Department of Education in China, No. 20102134120007.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Yan-ting Gu and Yi-xue Xue contributed equally to this study.
Rights and permissions
About this article
Cite this article
Gu, Yt., Xue, Yx., Zhang, H. et al. Adenosine 5′-Triphosphate-Sensitive Potassium Channel Activator Induces the Up-Regulation of Caveolin-1 Expression in a Rat Brain Tumor Model. Cell Mol Neurobiol 31, 629–634 (2011). https://doi.org/10.1007/s10571-011-9658-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10571-011-9658-5